Skip to main content
Erschienen in: Neurocritical Care 2/2017

04.01.2017 | Original Article

Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit

verfasst von: Karin Halvorson, Sameer Shah, Corey Fehnel, Bradford Thompson, N. Stevenson Potter, Mitchell Levy, Linda Wendell

Erschienen in: Neurocritical Care | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Fever is a common occurrence in the Neurocritical Care Unit (NCCU). It is reported that up to 50 % of these fevers are associated with a non-infectious source. As this is a diagnosis of exclusion, a complete fever evaluation must be done to rule out infection. Procalcitonin (PCT) has been identified as a possible biomarker to distinguish infectious from non-infectious etiologies of fever. We hypothesized that PCT could be used as a predictor of infectious fever in febrile patients with intracranial hemorrhage admitted to the NCCU.

Methods

A prospective observational cohort of patients admitted to a 12-bed NCCU in a tertiary-care university hospital from January 1, 2014, to October 1, 2014, was studied. Patients with intracranial hemorrhage (aneurismal subarachnoid hemorrhage, traumatic brain injury, intracerebral hemorrhage, or non-traumatic subdural hemorrhage) and fever defined as ≥101.4 °F were included. All patients had a urinalysis, chest X-ray, two sets of blood cultures, and PCT as part of their fever evaluation. Patients also had urine, sputum, CSF cultures, and Clostridium difficile toxin PCR as clinically indicated. Patients with incomplete fever evaluations were excluded.

Results

Seventy-three patients met inclusion criteria: 36 had infections identified and 37 did not. Type of intracranial hemorrhage was similar between groups. For those with identified infection, median PCT was 0.15 ng/mL (IQR 0.06–0.5 ng/mL). For those without identified infection, median PCT was 0.09 ng/mL (IQR 0.05–0.45 ng/mL), p = 0.30. Analyzing subgroups of intracranial hemorrhage patients revealed no group with a significant difference in PCT values. Patients with identified infection did have higher white blood cell counts (median 14.1 × 109/L (11.6–17.4 × 109/L) compared to those without identified infection 12 × 109/L (9.9–14.1 × 109/L), p = 0.02.

Conclusion

Among patients with intracranial hemorrhage, PCT did not differentiate infectious fever from non-infectious fever.
Literatur
1.
Zurück zum Zitat Rabinstein AA, Sandhu K. Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors. J Neurol Neurosurg Psychiatry. 2007;78(11):1278–80.CrossRefPubMedPubMedCentral Rabinstein AA, Sandhu K. Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors. J Neurol Neurosurg Psychiatry. 2007;78(11):1278–80.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology. 2003;60(5):837–41.CrossRefPubMed Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology. 2003;60(5):837–41.CrossRefPubMed
3.
Zurück zum Zitat Thompson HJ, Pinto-Martin J, Bullock MR. Neurogenic fever after traumatic brain injury: an epidemiological study. J Neurol Neurosurg Psychiatry. 2003;74(5):614–9.CrossRefPubMedPubMedCentral Thompson HJ, Pinto-Martin J, Bullock MR. Neurogenic fever after traumatic brain injury: an epidemiological study. J Neurol Neurosurg Psychiatry. 2003;74(5):614–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sung CY, Lee TH, Chu NS. Central hyperthermia in acute stroke. Eur Neurol. 2009;62(2):86–92.CrossRefPubMed Sung CY, Lee TH, Chu NS. Central hyperthermia in acute stroke. Eur Neurol. 2009;62(2):86–92.CrossRefPubMed
5.
Zurück zum Zitat Buratti T, et al. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation. 2001;25(2):97–100.CrossRefPubMed Buratti T, et al. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation. 2001;25(2):97–100.CrossRefPubMed
6.
Zurück zum Zitat Castelli GP, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234–42.CrossRefPubMedPubMedCentral Castelli GP, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234–42.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Harbarth S, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396–402.CrossRefPubMed Harbarth S, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396–402.CrossRefPubMed
8.
Zurück zum Zitat Matzaraki V, et al. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem. 2007;40(5–6):336–42.CrossRefPubMed Matzaraki V, et al. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem. 2007;40(5–6):336–42.CrossRefPubMed
9.
Zurück zum Zitat Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res. 1996;1(7):331–3.PubMed Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res. 1996;1(7):331–3.PubMed
10.
Zurück zum Zitat Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns. 2011;37(4):549–58.CrossRefPubMed Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns. 2011;37(4):549–58.CrossRefPubMed
11.
Zurück zum Zitat Muller B, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28(4):977–83.CrossRefPubMed Muller B, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28(4):977–83.CrossRefPubMed
12.
Zurück zum Zitat Wanner GA, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med. 2000;28(4):950–7.CrossRefPubMed Wanner GA, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med. 2000;28(4):950–7.CrossRefPubMed
13.
Zurück zum Zitat Rudy T, Pathogenesis of fever associated with cerebral trauma and intracranial hemorrhage. In: Cox B editor. Thermoregulatory mechanisms and therapeutic implications, Vol. 4th. International Symposium on the Pharmacology of Thermoregulation. Switzerland; 1980. Rudy T, Pathogenesis of fever associated with cerebral trauma and intracranial hemorrhage. In: Cox B editor. Thermoregulatory mechanisms and therapeutic implications, Vol. 4th. International Symposium on the Pharmacology of Thermoregulation. Switzerland; 1980.
14.
Zurück zum Zitat Dietrich WD, et al. Delayed posttraumatic brain hyperthermia worsens outcome after fluid percussion brain injury: a light and electron microscopic study in rats. Neurosurgery. 1996;38(3):533–41 discussion 541.PubMed Dietrich WD, et al. Delayed posttraumatic brain hyperthermia worsens outcome after fluid percussion brain injury: a light and electron microscopic study in rats. Neurosurgery. 1996;38(3):533–41 discussion 541.PubMed
15.
Zurück zum Zitat Suprin E, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000;26(9):1232–8.CrossRefPubMed Suprin E, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000;26(9):1232–8.CrossRefPubMed
16.
Zurück zum Zitat Ugarte H, et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27(3):498–504.CrossRefPubMed Ugarte H, et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27(3):498–504.CrossRefPubMed
17.
Zurück zum Zitat Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.CrossRefPubMed Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.CrossRefPubMed
18.
Zurück zum Zitat Ferrer R, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–55.CrossRefPubMed Ferrer R, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–55.CrossRefPubMed
19.
Zurück zum Zitat Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):33–40. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):33–40.
20.
Zurück zum Zitat Schuetz P, et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17(3):R115.CrossRefPubMedPubMedCentral Schuetz P, et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17(3):R115.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Friend KE, et al. Procalcitonin elevation suggests a septic source. Am Surg. 2014;80(9):906–9.PubMed Friend KE, et al. Procalcitonin elevation suggests a septic source. Am Surg. 2014;80(9):906–9.PubMed
22.
Zurück zum Zitat Liu HH, et al. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2016. doi:10.1007/s11845-016-1457-z. Liu HH, et al. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2016. doi:10.​1007/​s11845-016-1457-z.
24.
Zurück zum Zitat Festic E, et al. The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014;20(3):375–81.CrossRefPubMed Festic E, et al. The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014;20(3):375–81.CrossRefPubMed
Metadaten
Titel
Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit
verfasst von
Karin Halvorson
Sameer Shah
Corey Fehnel
Bradford Thompson
N. Stevenson Potter
Mitchell Levy
Linda Wendell
Publikationsdatum
04.01.2017
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 2/2017
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-016-0337-8

Weitere Artikel der Ausgabe 2/2017

Neurocritical Care 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.